Results 311 to 320 of about 700,872 (398)

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

International Journal of Cancer, EarlyView.
What's New? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar, Paula Lakrout, Valérie Potard, Aurélien Belot, Jacques Cadranel, Christine Jacomet, Christine Katlama, Esaïe Marshall, Olivier Lambotte, Romain Palich, Sylvie Ronot‐Bregigeon, Jean‐Philippe Spano, Anne‐Marie Bouvier, Alain Makinson, Dominique Costagliola   +14 more
wiley   +1 more source

Correction: Smartphone-Based Survey and Message Compliance in Adults Initially Unready to Quit Smoking: Secondary Analysis of a Randomized Controlled Trial. [PDF]

JMIR Form Res
Ulm C, Chen S, Fleshman B, Benson L, Kendzor DE, Frank-Pearce S, Neil JM, Vidrine D, De La Torre I, Businelle MS.   +9 more
europepmc   +1 more source

Impact of lung cancer screening eligibility criteria on participants' characteristics and healthcare resources

International Journal of Cancer, EarlyView.
What's New? Inclusion criteria for lung cancer screening (LCS) maintain cost control by focusing resources on select high‐risk groups. However, eligible individuals are inherently dissimilar in risk profile and demographics, potentially impacting LCS effectiveness and uptake.
María Olivia Cabrera, Kevin ten Haaf, Josep Maria Borràs, Rebeca Font, Judit Solà, Juul Hubert, Mónica Ballesteros, Josep Alfons Espinàs   +7 more
wiley   +1 more source

Quit Smoking: An Attainable Goal

, 2015
María Inés Sosa Liprandi, Julio Manuel Lewkowicz   +1 more
openalex   +1 more source

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

International Journal of Cancer, EarlyView.
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu, Li Zhang, Yun Fan, JianYing Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, GongYan Chen, Xin Zhang, CaiCun Zhou, Carmen González Arenas, Zhenghong Chen, Wen Cheng Yu, Tony S. K. Mok   +14 more
wiley   +1 more source

Desire to Quit Smoking, Opt-Out Tobacco Treatment, and Cessation: A Secondary Analysis of a Randomized Clinical Trial.

JAMA Netw Open
Gajewski B, Faseru B, Richter KP.
europepmc   +1 more source

Factors and reasons for planning to quit smoking among a nationally representative sample of adults who smoke: Findings from the 2021 ITC EUREST-PLUS Spain Survey. [PDF]

Tob Prev Cessat
Kaai SC, Fu M, Driezen P, Quah ACK, Yan M, Castellano Y, Tigova O, Fong GT, Fernández E.   +8 more
europepmc   +1 more source

Challenges in the future of cancer screening

International Journal of Cancer, EarlyView.
Abstract The purpose of cancer screening is to reduce mortality, and ideally incidence, from the cancer screened for. Until recently, cancer screening has been offered to all persons in pre‐defined sex‐ and age‐groups. The exception is lung screening which is targeted to high‐risk individuals.
Elsebeth Lynge, Berit Andersen, Stig E. Bojesen, Lone Kjeld Petersen, Mickael Bech, Martin Bøgsted, Mie Seest Dam, Søren Egstrand, Anne Mette Fløe Hvass, Camilla J. Kobylecki, Kristina Lång, Mads Nielsen, Giorgi Paolo Rossi, Michael Stenger, Ilse Vejborg, Future of Cancer Screening Working Group, Vibe Munk Bertelsen, Janne Bigaard, Karen Omann Binderup, Lennart Friis‐Hansen, Stine Bisgaard Greve, Jessica Xin Hjaltelin, Rikke Hedegaard Jensen, Gitte Jessing, Pia Kirkegaard, Mette Hartmann Nonboe, Tina Bech Olesen, Katrine Stolberg, Signe Bülow Therkildsen, Mette Kielsholm Thomsen   +29 more
wiley   +1 more source

Likely Response to a Hypothetical Menthol Cigarette Ban Among Adults with Mood Disorders Who Smoke Menthol Cigarettes and Have No Current Plans to Quit Smoking. [PDF]

Int J Environ Res Public Health
Mazhar L, Foulds J, Allen SI, Veldheer S, Hrabovsky S, Yingst JM.   +5 more
europepmc   +1 more source

No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects

International Journal of Cancer, EarlyView.
What's New? Venous thromboembolism (VTE) is common in cancer patients, with direct oral anticoagulants, including rivaroxaban, recommended as first‐line therapy. However, oral anticoagulant use is limited due to the growing use of targeted therapy and concerns about drug‐drug interactions.
Esther M. Hollander, Alessandra I. G. Buma, Jenneke Leentjens, Paddy K. C. Janssen, Michel M. van den Heuvel, David M. Burger, Berber Piet, Rob ter Heine   +7 more
wiley   +1 more source